Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gestational Trophoblastic Disease × toripalimab × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 17 Carcinoma, Non-Small-Cell Lung 15 Esophageal Squamous Cell Carcinoma 14 Breast Neoplasms 12 Triple Negative Breast Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 11 Small Cell Lung Carcinoma 8 Carcinoma, Hepatocellular 8 Stomach Neoplasms 7 Recurrence 6 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Sarcoma 4 Neoplasm Metastasis 4 Melanoma 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Renal Cell 4 Rectal Neoplasms 3 Locally Advanced Rectal Cancer 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Microsatellite Stable Metastatic Colorectal Cancer 2 Liver Neoplasms 2 Klatskin Tumor 2

Interventions

camrelizumab 3 pembrolizumab 2 apatinib 2 Methylprednisolone 2 Dactinomycin 2 Alemtuzumab 2 zimberelimab 1 toripalimab 1 sargramostim 1 dostarlimab 1 carotuximab 1 aldesleukin 1 Tacrolimus 1 Specimen Handling 1 Prednisone 1 Pemetrexed 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Interferon-alpha 1 Injections 1 Immunologic Techniques 1 Flow Cytometry 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06020755 2024-12-31

TA7

Peking Union Medical College Hospital

Phase 2 Recruiting

Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡